Details of the Drug Reposition

General Information of This Drug (ID: DMKGEBB)

Drug Name
DOV-216419   DMKGEBB
Synonyms Triple serotonin/dopamine/norepinephrine reuptake inhibitor (depression/pain), Dov; Triple serotonin/dopamine/norepinephrine reuptake inhibitor (depression/pain), Euthymics
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Attention deficit hyperactivity disorder DISL8MX9 6A05.Z Phase 3 [1]
------------------------------------------------------------------------------------
1 Investigative Indication(s)
Indication Name Indication ID ICD-11 Status REF
Major depressive disorder DIS4CL3X 6A70.3 Investigative [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03605849) A Trial Evaluating the Long-term Safety and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder. U.S. National Institutes of Health.
2 The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.